Independent Factors for Prediction of Poor Outcomes in Patients with Febrile Neutropenia

被引:0
|
作者
Gunalp, Muge [1 ]
Koyunoglu, Merve [1 ]
Gurler, Serdar [1 ]
Koca, Ayca [1 ]
Yesilkaya, Ilker [1 ]
Oner, Emre [1 ]
Akkas, Meltem [2 ]
Aksu, Nalan Metin [2 ]
Demirkan, Arda [1 ]
Polat, Onur [1 ]
Elhan, Atilla Halil [3 ]
机构
[1] Ankara Univ, Sch Med, Dept Emergency Med, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Emergency Med, Ankara, Turkey
[3] Ankara Univ, Sch Med, Dept Biostat, TR-06100 Ankara, Turkey
来源
MEDICAL SCIENCE MONITOR | 2014年 / 20卷
关键词
Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Emergencies; CLINICAL-PRACTICE GUIDELINE; CANCER-RISK INDEX; MULTINATIONAL-ASSOCIATION; EMERGENCY-DEPARTMENT; SUPPORTIVE-CARE; HEMATOLOGIC MALIGNANCIES; FEVER; MANAGEMENT; DISCHARGE; DISEASE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Febrile neutropenia (FN) is a life-threatening condition that requires urgent management in the emergency department (ED). Recent progress in the treatment of neutropenic fever has underscored the importance of risk stratification. In this study, we aimed to determine independent factors for prediction of poor outcomes in patients with FN. Material/Methods: We retrospectively evaluated 200 chemotherapy-induced febrile neutropenic patients who visited the ED. Upon arrival at the ED, clinical data, including sex, age, vital signs, underlying systemic diseases, laboratory test results, estimated GFR, blood cultures, CRP, radiologic examinations, and Multinational Association of Supportive Care in Cancer (MASCC) score of all febrile neutropenic patients were obtained. Outcomes were categorized as "poor" if serious complications during hospitalization, including death, occurred. Results: The platelet count <50 000 cells/mm(3) (OR 3.90, 95% CI 1.62-9.43), pulmonary infiltration (OR 3.45, 95% CI 1.48-8.07), hypoproteinemia <6 g/dl (OR 3.30, 95% CI 1.27-8.56), respiratory rate >24/min (OR 8.75, 95% CI 2.18-35.13), and MASCC score <21 (OR 9.20, 95% CI 3.98-21.26) were determined as independent risk factors for the prediction of death. The platelet count <50 000 cells/mm(3) (OR 3.93, 95% CI 1.42-10.92), serum CRP >50 mg/dl (OR 3.80, 95% CI 1.68-8.61), hypoproteinemia (OR 7.81, 95% CI 3.43-17.78), eGFR <= 90 ML/min/1.73 m(2) (OR 3.06, 95% CI 1.13-8.26), and MASCC score <21 (OR 3.45, 95% CI 1.53-7.79) were determined as independent risk factors for the prediction of poor clinical outcomes of FN patients. Platelet count, protein level, respiratory rate, pulmonary infiltration, CRP, MASCC score, and eGFR were shown to have a significant association with outcome. Conclusions: The results of our study may help emergency medicine physicians to prevent serious complications with proper use of simple independent risk factors besides MASCC score.
引用
收藏
页码:1826 / 1832
页数:7
相关论文
共 50 条
  • [41] Procalcitonin in cancer patients with febrile neutropenia
    Uys, A.
    Rapoport, B. L.
    Fickl, H.
    Meyer, P. W. A.
    Anderson, R.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 378 - 378
  • [42] Brucellosis in all patients with febrile neutropenia
    Metan, Gokhan
    Sardan, Yesim Cetinkaya
    Hascelik, Gulsen
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (05) : 954 - 956
  • [43] Microbiological data for patients with febrile neutropenia
    Kanamaru, A
    Tatsumi, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 : S7 - S10
  • [44] Factors Associated with Hospital Length of Stay among Cancer Patients with Febrile Neutropenia
    Rosa, Regis G.
    Goldani, Luciano Z.
    [J]. PLOS ONE, 2014, 9 (10):
  • [45] Analysis of the Risk Factors for Febrile Neutropenia in Patients with Bone and Soft Tissue Sarcoma
    Aoyagi, Takayuki
    Morii, Takeshi
    Tajima, Takashi
    Yoshiyama, Akira
    Ichimura, Shoichi
    [J]. ANTICANCER RESEARCH, 2015, 35 (04) : 2375 - 2383
  • [46] RISK FACTORS TO DEVELOP A SEVERE INFECTION IN PEDIATRIC ONCOLOGY PATIENTS WITH FEBRILE NEUTROPENIA
    Mata Fernandez, C.
    Santiago Garcia, B.
    Hernandez Ruperez, B.
    Herraiz, R.
    Casas Fleca, I.
    Sautu, U.
    Garrido Colino, C.
    Huerta Aragones, J.
    Saavedra Lozano, J.
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S244 - S244
  • [47] Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients With Febrile Neutropenia
    Techavichit, P.
    Thangthong, J.
    Anugulruengkitt, S.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S160 - S161
  • [48] Clinical factors predictive of recurrent febrile neutropenia in adult patients with acute leukemia
    Wanitpongpun, Chinadol
    Teawtrakul, Nattiya
    Lanamtieng, Theerin
    Chansung, Kanchana
    Sirijeerachai, Chittima
    Amampai, Worakamol
    Sawanyawisuth, Kittisak
    [J]. LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [49] PREDICTIVE FACTORS FOR THE DEVELOPMENT OF FEBRILE NEUTROPENIA IN PANCREATIC CANCER PATIENTS RECEIVING FOLFIRINOX
    Keum, Jiyoung
    Lee, Hee Seung
    Jo, Jung Hyun
    Kang, Huapyong
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S327 - S328
  • [50] Examining health-related quality of life in pediatric cancer patients with febrile neutropenia: Factors predicting poor recovery in children and their parents
    Crothers, Anna
    Haeusler, Gabrielle M.
    Slavin, Monica A.
    Babl, Franz E.
    Mechinaud, Francoise
    Phillips, Robert
    Tapp, Heather
    Padhye, Bhavna
    Zeigler, David
    Clark, Julia
    Walwyn, Thomas
    Super, Leanne
    Alvaro, Frank
    Thursky, Karin
    Lourenco, Richard De Abreu
    [J]. ECLINICALMEDICINE, 2021, 40